13F HOLDINGS REPORT
RiverVest Venture Management LLC
Quarter ended Q4 2023 · Filed October 30, 2023 · Accession 0001104659-23-112611
Total Value
$40.4M
Positions
5
Other Managers
0
Confidential Omitted
No
Holdings (5)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Reneo Pharmaceuticals, Inc. | 75974E103 | 2,534,220 | $19.3M | 47.73% |
| 2 | Allakos, Inc. | 01671P100 | 4,987,522 | $11.3M | 28.00% |
| 3 | Spruce Bioscience, Inc. | SPRB | 2,936,281 | $6.6M | 16.41% |
| 4 | Xilio Therapeutics, Inc. | XLO | 1,441,444 | $3.0M | 7.52% |
| 5 | Vapotherm, Inc. | 922107107 | 52,552 | $132,965 | 0.33% |